Workflow
三友医疗: 东方证券股份有限公司关于上海三友医疗器械股份有限公司部分募投项目结项的核查意见
600958Orient Securities(600958) 证券之星·2025-03-26 13:25

Core Viewpoint - The company has completed the "Marketing Network Construction Project" and plans to manage the remaining raised funds through cash management or temporarily supplement working capital, following the necessary regulatory approvals [1][6][7] Fundraising Overview - The company raised a total of RMB 1,075,950,160.00 by issuing 51,333,500 shares at RMB 20.96 per share, with net proceeds of RMB 978,057,381.28 after deducting issuance costs [1][2] - The total investment amount for the projects disclosed in the prospectus is RMB 62,200.00 million, with RMB 60,000.00 million planned to be funded from the raised capital [2] Project Completion and Fund Usage - The "Marketing Network Construction Project" has been completed with a usage progress of 92.70%, resulting in a surplus of funds due to effective cost control and management [4][5] - As of December 31, 2024, the remaining funds in the project account amount to RMB 1,021.67 million, including cash management funds and earnings [3][4] Reasons for Fund Surplus - The surplus is attributed to prudent fund usage, ensuring project quality while controlling costs, leading to a total interest income of RMB 458.09 million from cash management [4][5] Future Fund Management Plan - The surplus funds will be temporarily managed as cash or used to supplement working capital, with a usage period not exceeding 12 months from the board's approval date [5] Decision-Making Process - The board and supervisory committee have approved the project completion and the plan for surplus fund management, confirming compliance with relevant regulations and ensuring no harm to shareholder interests [5][6]